๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients

โœ Scribed by Johnson, A G; Pearce, G L; Danoff, T M


Book ID
110048976
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
120 KB
Volume
20
Category
Article
ISSN
0950-9240

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


A multicentre, randomized, double-blind,
โœ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 139 KB ๐Ÿ‘ 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre